ARCHER1050: A Study of Dacomitinib vs. Gefitinib in 1st-Line Treatment Of Advanced NSCLC.

Clinical trial NCT01774721 · COMPLETED

Trial details

NCT number: NCT01774721
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer With EGFR-Activating Mutations

Start date: 2013-05-09
Primary completion: 2016-07-29
Enrollment: 452

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.